ArticleInternational journal of molecular sciences2025

Synergistic Efficacy of Gedatolisib and Darolutamide in Prostate Cancer to Overcome Resistance to Androgen-Targeted Therapy.

Salmaan Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.